SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001664710-22-000040
Filing Date
2022-08-04
Accepted
2022-08-04 16:56:56
Documents
52
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kros-20220630.htm   iXBRL 10-Q 1229211
2 EX-31.1 exhibit311q22022.htm EX-31.1 17335
3 EX-31.2 exhibit312q22022.htm EX-31.2 17216
4 EX-32.1 exhibit321q22022.htm EX-32.1 9947
  Complete submission text file 0001664710-22-000040.txt   4047108

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kros-20220630.xsd EX-101.SCH 24151
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kros-20220630_cal.xml EX-101.CAL 41746
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kros-20220630_def.xml EX-101.DEF 78868
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kros-20220630_lab.xml EX-101.LAB 329976
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kros-20220630_pre.xml EX-101.PRE 201615
46 EXTRACTED XBRL INSTANCE DOCUMENT kros-20220630_htm.xml XML 452831
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39264 | Film No.: 221137518
SIC: 2834 Pharmaceutical Preparations